Trial Profile
Multi-center, randomized, open, uncontrolled study to investigate the efficacy and safety of a 4 phasic oral contraceptive SH T00658 [estradiol-valerate/dienogest] in a 28-day regimen for 20 cycles in healthy female volunteers.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2020
Price :
$35
*
At a glance
- Drugs Estradiol valerate/dienogest (Primary) ; Estradiol valerate
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- 03 May 2008 Results were reported at the 10th Congress of the European Society of Contraception.
- 29 Sep 2006 Status change
- 17 Nov 2005 New trial record.